Stock Market Reviews

Read and share opinions on ACHV (Achieve Life Sciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

Latest News

• ACHV: FDA’s CNPV Awarded for Vaping
  Nov 10, 2025
• Achieve Life Sciences Inc (ACHV) Q3 2025 Earnings Call Highlights: Strategic Advances and ...
  Nov 6, 2025
• Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
  Nov 6, 2025
• Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
  Nov 3, 2025
• Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
  Oct 29, 2025
• Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
  Oct 20, 2025
• A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy
  Oct 18, 2025
• Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
  Oct 17, 2025
• Achieve Life Sciences Announces Granting of New Hire Inducement Awards
  Oct 2, 2025
• Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD
  Sep 22, 2025
• ACHV: Preparations Continue as PDUFA Date Assigned
  Sep 22, 2025
• Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer
  Sep 18, 2025
• Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
  Sep 11, 2025
• Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
  Sep 3, 2025
• Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
  Sep 2, 2025
• Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years
  Aug 21, 2025